Pemetrexed with or without matuzumab as second-line treatment for patients with stage IIIB/IV non-small cell lung cancer
This randomized phase II study investigated pemetrexed in combination with the epidermal growth factor receptor (EGFR)-targeting monoclonal antibody matuzumab compared with pemetrexed alone as second-line therapy for patients with advanced non-small cell lung cancer.
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2010
|
| In: |
Journal of thoracic oncology
Year: 2010, Jahrgang: 5, Heft: 12, Pages: 1977-1985 |
| ISSN: | 1556-1380 |
| DOI: | 10.1097/JTO.0b013e3181f4a5c9 |
| Online-Zugang: | Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.1097/JTO.0b013e3181f4a5c9 Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S1556086415318712 
|
| Verfasserangaben: | Joan H. Schiller, Joachim von Pawel, Philipp Schütt, Rafat H. Ansari, Michael Thomas, Mansoor Saleh, Robert D. McCroskey, Wolfgang Pfeifer, Thomas A. Marsland, Goetz H. Kloecker, Martin Sebastian, Robert Pirker, Raffael Kurek, Claire Beadman, and Mark A. Socinski |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1847641318 | ||
| 003 | DE-627 | ||
| 005 | 20230710131340.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230607s2010 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1097/JTO.0b013e3181f4a5c9 |2 doi | |
| 035 | |a (DE-627)1847641318 | ||
| 035 | |a (DE-599)KXP1847641318 | ||
| 035 | |a (OCoLC)1389793969 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Schiller, Joan H. |e VerfasserIn |0 (DE-588)1292240393 |0 (DE-627)1847642454 |4 aut | |
| 245 | 1 | 0 | |a Pemetrexed with or without matuzumab as second-line treatment for patients with stage IIIB/IV non-small cell lung cancer |c Joan H. Schiller, Joachim von Pawel, Philipp Schütt, Rafat H. Ansari, Michael Thomas, Mansoor Saleh, Robert D. McCroskey, Wolfgang Pfeifer, Thomas A. Marsland, Goetz H. Kloecker, Martin Sebastian, Robert Pirker, Raffael Kurek, Claire Beadman, and Mark A. Socinski |
| 246 | 3 | 0 | |a IIIB / IV |
| 264 | 1 | |c 2010 | |
| 300 | |a 9 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 07.06.2023 | ||
| 520 | |a This randomized phase II study investigated pemetrexed in combination with the epidermal growth factor receptor (EGFR)-targeting monoclonal antibody matuzumab compared with pemetrexed alone as second-line therapy for patients with advanced non-small cell lung cancer. | ||
| 650 | 4 | |a EGFR | |
| 650 | 4 | |a Humanized monoclonal antibody | |
| 650 | 4 | |a Matuzumab | |
| 650 | 4 | |a NSCLC | |
| 650 | 4 | |a Pemetrexed | |
| 650 | 4 | |a Second-line | |
| 700 | 1 | |a von Pawel, Joachim |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schütt, Philipp |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ansari, Rafat H. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Thomas, Michael |e VerfasserIn |0 (DE-588)1054438781 |0 (DE-627)79152213X |0 (DE-576)41027089X |4 aut | |
| 700 | 1 | |a Saleh, Mansoor |e VerfasserIn |4 aut | |
| 700 | 1 | |a McCroskey, Robert D. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Pfeifer, Wolfgang |e VerfasserIn |4 aut | |
| 700 | 1 | |a Marsland, Thomas A. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kloecker, Goetz H. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Sebastian, Martin |e VerfasserIn |4 aut | |
| 700 | 1 | |a Pirker, Robert |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kurek, Raffael |e VerfasserIn |4 aut | |
| 700 | 1 | |a Beadman, Claire |e VerfasserIn |4 aut | |
| 700 | 1 | |a Socinski, Mark A. |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of thoracic oncology |d Amsterdam : Elsevier, 2006 |g 5(2010), 12 vom: Dez., Seite 1977-1985 |h Online-Ressource |w (DE-627)508331986 |w (DE-600)2223437-8 |w (DE-576)336961553 |x 1556-1380 |7 nnas |a Pemetrexed with or without matuzumab as second-line treatment for patients with stage IIIB/IV non-small cell lung cancer |
| 773 | 1 | 8 | |g volume:5 |g year:2010 |g number:12 |g month:12 |g pages:1977-1985 |g extent:9 |a Pemetrexed with or without matuzumab as second-line treatment for patients with stage IIIB/IV non-small cell lung cancer |
| 856 | 4 | 0 | |u https://doi.org/10.1097/JTO.0b013e3181f4a5c9 |x Resolving-System |x Verlag |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.sciencedirect.com/science/article/pii/S1556086415318712 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20230607 | ||
| 993 | |a Article | ||
| 994 | |a 2010 | ||
| 998 | |g 1054438781 |a Thomas, Michael |m 1054438781:Thomas, Michael |d 910000 |d 950000 |d 950900 |e 910000PT1054438781 |e 950000PT1054438781 |e 950900PT1054438781 |k 0/910000/ |k 1/910000/950000/ |k 2/910000/950000/950900/ |p 5 | ||
| 999 | |a KXP-PPN1847641318 |e 4330023113 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"name":{"displayForm":["Joan H. Schiller, Joachim von Pawel, Philipp Schütt, Rafat H. Ansari, Michael Thomas, Mansoor Saleh, Robert D. McCroskey, Wolfgang Pfeifer, Thomas A. Marsland, Goetz H. Kloecker, Martin Sebastian, Robert Pirker, Raffael Kurek, Claire Beadman, and Mark A. Socinski"]},"title":[{"title":"Pemetrexed with or without matuzumab as second-line treatment for patients with stage IIIB/IV non-small cell lung cancer","title_sort":"Pemetrexed with or without matuzumab as second-line treatment for patients with stage IIIB/IV non-small cell lung cancer"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"person":[{"role":"aut","display":"Schiller, Joan H.","family":"Schiller","given":"Joan H."},{"display":"von Pawel, Joachim","role":"aut","family":"von Pawel","given":"Joachim"},{"role":"aut","display":"Schütt, Philipp","family":"Schütt","given":"Philipp"},{"given":"Rafat H.","family":"Ansari","display":"Ansari, Rafat H.","role":"aut"},{"family":"Thomas","role":"aut","display":"Thomas, Michael","given":"Michael"},{"display":"Saleh, Mansoor","role":"aut","family":"Saleh","given":"Mansoor"},{"role":"aut","display":"McCroskey, Robert D.","family":"McCroskey","given":"Robert D."},{"given":"Wolfgang","family":"Pfeifer","role":"aut","display":"Pfeifer, Wolfgang"},{"given":"Thomas A.","family":"Marsland","display":"Marsland, Thomas A.","role":"aut"},{"display":"Kloecker, Goetz H.","role":"aut","family":"Kloecker","given":"Goetz H."},{"given":"Martin","display":"Sebastian, Martin","role":"aut","family":"Sebastian"},{"family":"Pirker","display":"Pirker, Robert","role":"aut","given":"Robert"},{"given":"Raffael","family":"Kurek","display":"Kurek, Raffael","role":"aut"},{"family":"Beadman","role":"aut","display":"Beadman, Claire","given":"Claire"},{"display":"Socinski, Mark A.","role":"aut","family":"Socinski","given":"Mark A."}],"id":{"eki":["1847641318"],"doi":["10.1097/JTO.0b013e3181f4a5c9"]},"origin":[{"dateIssuedDisp":"2010","dateIssuedKey":"2010"}],"language":["eng"],"note":["Gesehen am 07.06.2023"],"relHost":[{"disp":"Pemetrexed with or without matuzumab as second-line treatment for patients with stage IIIB/IV non-small cell lung cancerJournal of thoracic oncology","title":[{"title_sort":"Journal of thoracic oncology","title":"Journal of thoracic oncology","subtitle":"JTO ; official publication of the International Association for the Study of Lung Cancer"}],"origin":[{"dateIssuedDisp":"2006-","publisherPlace":"Amsterdam ; Philadelphia, Pa.","dateIssuedKey":"2006","publisher":"Elsevier ; Lippincott Williams & Wilkins"}],"part":{"volume":"5","extent":"9","issue":"12","pages":"1977-1985","text":"5(2010), 12 vom: Dez., Seite 1977-1985","year":"2010"},"id":{"zdb":["2223437-8"],"issn":["1556-1380"],"eki":["508331986"]},"language":["eng"],"pubHistory":["1.2006 -"],"type":{"media":"Online-Ressource","bibl":"periodical"},"titleAlt":[{"title":"JTO"}],"physDesc":[{"extent":"Online-Ressource"}],"recId":"508331986"}],"recId":"1847641318","physDesc":[{"extent":"9 S."}]} | ||
| SRT | |a SCHILLERJOPEMETREXED2010 | ||